RSV, or respiratory syncytial virus, is a common cause of cold-like symptoms but it can be dangerous for infants and the elderly.
may be coming too, pending approval from the Food and Drug Administration., signed off on a recommendation made last week by an advisory panel of outside experts for a single dose of the vaccines made by Pfizer and GSK. The FDA approved the shots last month for adults 60 and older.
The CDC panel initially considered a stronger recommendation that everyone 65 and older get the shot. But they weakened their endorsement after several members had questions about how well it works in the feeblest of patients, whether boosters will be needed and be effective, and the cost. Drugmaker GSK told the panel that its RSV vaccine would be between $200 and $295. Pfizer has not disclosed a price. The vaccines may hold up over multiple seasons and it’s not yet clear whether boosters will be recommended.
Others wanted a stronger endorsement for those 65 and older. That would have meant more people getting the vaccination, said Robert Blancato, executive director of the National Association of Nutrition and Aging Services Programs, in a statement after the panel’s vote.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
RSV Vaccines for Older Adults Should Be Here by the FallThe CDC's advisory committee recommended this month that adults over 60 can receive one of two RSV vaccines, setting the stage for wide distribution this year.
Baca lebih lajut »
CDC: Pregnant women with COVID were older, whiter, more educated as disease evolvedPregnant women with suspected or confirmed COVID-19 infections were likely to be older, whiter and more educated as the pandemic unfolded, the Centers for Disease Control and Prevention reported Wednesday.
Baca lebih lajut »
An RSV vaccine is being recommended for older adults, but a Penn survey found most know little about the diseaseDaily News | An RSV vaccine is being recommended for older adults, but a Penn survey found most know little about the disease
Baca lebih lajut »
Treating cancer in older patients poses different complications and risksPeople over 70 have a heightened risk of cancer, but are under-represented in clinical trials of new drugs. That can be dangerous. (via undarkmag)
Baca lebih lajut »